Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1998 2
1999 2
2004 1
2005 2
2006 2
2008 1
2009 1
2010 1
2011 2
2012 1
2019 1
2020 1
2022 3
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Skin adenosquamous carcinoma"
Page 1
Survival with Cemiplimab in Recurrent Cervical Cancer.
Tewari KS, Monk BJ, Vergote I, Miller A, de Melo AC, Kim HS, Kim YM, Lisyanskaya A, Samouëlian V, Lorusso D, Damian F, Chang CL, Gotovkin EA, Takahashi S, Ramone D, Pikiel J, Maćkowiak-Matejczyk B, Guerra Alía EM, Colombo N, Makarova Y, Rischin D, Lheureux S, Hasegawa K, Fujiwara K, Li J, Jamil S, Jankovic V, Chen CI, Seebach F, Weinreich DM, Yancopoulos GD, Lowy I, Mathias M, Fury MG, Oaknin A; Investigators for GOG Protocol 3016 and ENGOT Protocol En-Cx9. Tewari KS, et al. N Engl J Med. 2022 Feb 10;386(6):544-555. doi: 10.1056/NEJMoa2112187. N Engl J Med. 2022. PMID: 35139273 Clinical Trial.
Cemiplimab, the fully human programmed cell death 1 (PD-1)-blocking antibody approved to treat lung and skin cancers, has been shown to have preliminary clinical activity in this population. ...The overall survival benefit was consistent in both histologic subgroups (squam …
Cemiplimab, the fully human programmed cell death 1 (PD-1)-blocking antibody approved to treat lung and skin cancers, has been shown …
High-risk cutaneous squamous cell carcinoma.
Nuño-González A, Vicente-Martín FJ, Pinedo-Moraleda F, López-Estebaranz JL. Nuño-González A, et al. Actas Dermosifiliogr. 2012 Sep;103(7):567-78. doi: 10.1016/j.ad.2011.09.005. Epub 2012 Jan 17. Actas Dermosifiliogr. 2012. PMID: 22261673 Free article. Review. English, Spanish.
Cutaneous squamous cell carcinoma (cSCC) is the second most common form of skin cancer and its incidence has increased in recent decades. Most cSCCs are successfully treated by surgery, but local and distant metastases develop in approximately 5% of cases; this prop …
Cutaneous squamous cell carcinoma (cSCC) is the second most common form of skin cancer and its incidence has increased in rece …
Squamous cell cancer: a practical approach.
Goldman GD. Goldman GD. Semin Cutan Med Surg. 1998 Jun;17(2):80-95. doi: 10.1016/s1085-5629(98)80002-3. Semin Cutan Med Surg. 1998. PMID: 9669602 Review.
Cutaneous squamous cell carcinoma (SCC) is the second most common form of skin cancer and is treated frequently by dermatologists. For many years, the level of knowledge regarding treatment of SCC has taken a backseat to the treatment of basal cell carcinoma …
Cutaneous squamous cell carcinoma (SCC) is the second most common form of skin cancer and is treated frequently by dermatologi …
Squamous cell carcinoma of the skin.
Rudolph R, Zelac DE. Rudolph R, et al. Plast Reconstr Surg. 2004 Nov;114(6):82e-94e. doi: 10.1097/01.prs.0000138243.45735.8a. Plast Reconstr Surg. 2004. PMID: 15509920 Review.
After studying this article, the participant should be able to: 1. Identify the subtypes of squamous cell carcinoma of the skin. 2. Identify factors that affect recurrence and/or metastasis. 3. Develop a surgical management plan for treating high-risk squamous cell …
After studying this article, the participant should be able to: 1. Identify the subtypes of squamous cell carcinoma of the skin …
Cutaneous squamous cell carcinoma: a comprehensive clinicopathologic classification--part two.
Cassarino DS, Derienzo DP, Barr RJ. Cassarino DS, et al. J Cutan Pathol. 2006 Apr;33(4):261-79. doi: 10.1111/j.0303-6987.2006.00516.x. J Cutan Pathol. 2006. PMID: 16630176 Review.
Low-risk SCCs include SCC arising in actinic keratosis, HPV-associated SCC, tricholemmal carcinoma, and spindle cell SCC (unassociated with radiation). Intermediate-risk SCCs include adenoid (acantholytic) SCC, intraepidermal epithelioma with invasion, and lymphoepitheliom …
Low-risk SCCs include SCC arising in actinic keratosis, HPV-associated SCC, tricholemmal carcinoma, and spindle cell SCC (unassociate …
Cutaneous squamous cell carcinoma: a comprehensive clinicopathologic classification. Part one.
Cassarino DS, Derienzo DP, Barr RJ. Cassarino DS, et al. J Cutan Pathol. 2006 Mar;33(3):191-206. doi: 10.1111/j.0303-6987.2006.00516_1.x. J Cutan Pathol. 2006. PMID: 16466506 Review.
Low-risk SCCs include SCC arising in actinic keratosis, HPV-associated SCC, tricholemmal carcinoma, and spindle cell SCC (unassociated with radiation). Intermediate-risk SCCs include adenoid (acantholytic) SCC, intraepidermal epithelioma with invasion, and lymphoepitheliom …
Low-risk SCCs include SCC arising in actinic keratosis, HPV-associated SCC, tricholemmal carcinoma, and spindle cell SCC (unassociate …
Adenosquamous carcinoma of the skin: a case series.
Fu JM, McCalmont T, Yu SS. Fu JM, et al. Arch Dermatol. 2009 Oct;145(10):1152-8. doi: 10.1001/archdermatol.2009.218. Arch Dermatol. 2009. PMID: 19841403
BACKGROUND: Adenosquamous carcinoma is an uncommon cutaneous malignant neoplasm with mixed glandular and squamous differentiation and a propensity for aggressive clinical behavior. OBSERVATIONS: Of 27 patients diagnosed as having adenosquamous carcinoma …
BACKGROUND: Adenosquamous carcinoma is an uncommon cutaneous malignant neoplasm with mixed glandular and squamous differentiat …
CDX2 expression in primary skin tumors-case series and review of the literature.
Tekin B, Kundert P, Yang HH, Guo R. Tekin B, et al. Hum Pathol. 2022 Nov;129:1-10. doi: 10.1016/j.humpath.2022.07.013. Epub 2022 Aug 1. Hum Pathol. 2022. PMID: 35926811 Review.
Among them, 11 cases confirmed as primary nonintestinal type cutaneous carcinoma with definitively positive CDX2 nuclear staining were further studied. ...Cases 1-5 had heterogeneous features that cannot be further classified, including 2 cases with neuroendocrine or pseud …
Among them, 11 cases confirmed as primary nonintestinal type cutaneous carcinoma with definitively positive CDX2 nuclear staining wer …
Precancer of the human cervix.
Pontén J, Guo Z. Pontén J, et al. Cancer Surv. 1998;32:201-29. Cancer Surv. 1998. PMID: 10489629 Review.
A large variety of individually distinct forms crudely divided into slight, moderate, severe dysplasia and carcinoma in situ exist. Virtually all contain genital human papillomavirus (HPV) either as infectious virions or as episomal or integrated DNA. ...Low risk types are …
A large variety of individually distinct forms crudely divided into slight, moderate, severe dysplasia and carcinoma in situ exist. V …
Adenosquamous carcinoma of the pancreas: a single-institution experience comparing resection and palliative care.
Smoot RL, Zhang L, Sebo TJ, Que FG. Smoot RL, et al. J Am Coll Surg. 2008 Sep;207(3):368-70. doi: 10.1016/j.jamcollsurg.2008.03.027. Epub 2008 May 15. J Am Coll Surg. 2008. PMID: 18722942

BACKGROUND: Adenosquamous carcinoma is a rare malignancy of the exocrine pancreas. ...A p value < 0.05 was considered significant. RESULTS: Twenty-three patients were identified with adenosquamous carcinoma of the pancreas. Twelve patients underwent

…

BACKGROUND: Adenosquamous carcinoma is a rare malignancy of the exocrine pancreas. ...A p value < 0.05 was considered signi

…
21 results